HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Local Delivery of Single Dose Intra Epiphyseal Bisphosphonates to Prevent the Progression of Legg-Calve-Perthes Disease - Case Series.

AbstractINTRODUCTION:
Legg-Calve´-Perthes disease (LCPD) or avascular necrosis of the capital epiphysis is an idiopathic disease characterized by interruption of the blood supply to the capital femoral epiphysis resulting in necrosis of the epiphysis. There are a variety of treatment modalities such as containment with braces early in disease to surgical procedures for children presenting late in their age group. The newer modalities of treatment are intravenous bisphosphonates, bone morphogenic protein in clinical subjects.
CASE REPORT:
Two children (Aged 7 years with catterall Stage II unilateral affection, aged 11 years catterall Stage III bilateral affection) were advised single-dose of zoledronic acid(2 mg) into epiphysis as day care procedure after due discussion with parents about other treatment modalities. Both the children were followed up quarterly with clinical examination and radiology. At the latest follow-up of 4 years both had satisfactory outcome. Child one was able to do normal play with intact lateral pillar. Child two had minimal collapse of left hip however clinically pain free.
CONCLUSION:
Local delivery of single dose of intra epiphyseal zoledronic acid is a relatively harmless procedure and effective in preventing the progression of disease pathology, especially in children with age group of 6-10 years.
AuthorsR Sivakumar, V Somashekar, Prahalad Kumar Singhi, M Chidambaram
JournalJournal of orthopaedic case reports (J Orthop Case Rep) 2020 Aug-Sep Vol. 10 Issue 5 Pg. 65-68 ISSN: 2250-0685 [Print] India
PMID33312983 (Publication Type: Case Reports)
CopyrightCopyright: © Indian Orthopaedic Research Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: